Literature DB >> 11485646

Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?

F R Mooi1, I H van Loo, A J King.   

Abstract

In the Netherlands, as in many other western countries, pertussis vaccines have been used extensively for more than 40 years. Therefore, it is conceivable that vaccine-induced immunity has affected the evolution of Bordetella pertussis. Consistent with this notion, pertussis has reemerged in the Netherlands, despite high vaccination coverage. Further, a notable change in the population structure of B. pertussis was observed in the Netherlands subsequent to the introduction of vaccination in the 1950s. Finally, we observed antigenic divergence between clinical isolates and vaccine strains, in particular with respect to the surface-associated proteins pertactin and pertussis toxin. Adaptation may have allowed B. pertussis to remain endemic despite widespread vaccination and may have contributed to the reemergence of pertussis in the Netherlands.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485646      PMCID: PMC2631860          DOI: 10.3201/eid0707.017708

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  16 in total

1.  Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children.

Authors:  Paola Mastrantonio; Patrizia Spigaglia; Hans van Oirschot; Han G J van der Heide; Kees Heuvelman; Paola Stefanelli; Frits R Mooi
Journal:  Microbiology       Date:  1999-08       Impact factor: 2.777

2.  Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population.

Authors:  I H van Loo; H G van der Heide; N J Nagelkerke; J Verhoef; F R Mooi
Journal:  J Infect Dis       Date:  1999-04       Impact factor: 5.226

3.  Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999.

Authors:  P Cassiday; G Sanden; K Heuvelman; F Mooi; K M Bisgard; T Popovic
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

4.  Pertussis notifications in Australia, 1991 to 1997.

Authors:  R Andrews; A Herceg; C Roberts
Journal:  Commun Dis Intell       Date:  1997-05-29

5.  Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells.

Authors:  P Everest; J Li; G Douce; I Charles; J De Azavedo; S Chatfield; G Dougan; M Roberts
Journal:  Microbiology       Date:  1996-11       Impact factor: 2.777

6.  Pertussis in Quebec: ongoing epidemic since the late 1980s.

Authors:  G De Serres; N Boulianne; M Douville Fradet; B Duval
Journal:  Can Commun Dis Rep       Date:  1995-03-15

7.  Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution.

Authors:  F R Mooi; H van Oirschot; K Heuvelman; H G van der Heide; W Gaastra; R J Willems
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  Incidence of pertussis infection in healthcare workers.

Authors:  S W Wright; M D Decker; K M Edwards
Journal:  Infect Control Hosp Epidemiol       Date:  1999-02       Impact factor: 3.254

9.  Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.

Authors:  H E de Melker; M A Conyn-van Spaendonck; H C Rümke; J K van Wijngaarden; F R Mooi; J F Schellekens
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

10.  A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.

Authors:  J D Cherry; J Gornbein; U Heininger; K Stehr
Journal:  Vaccine       Date:  1998-12       Impact factor: 3.641

View more
  76 in total

1.  Reproducibility of Bordetella pertussis genomic DNA fragments generated by XbaI restriction and resolved by pulsed-field gel electrophoresis.

Authors:  Terri H Hardwick; Brian Plikaytis; Pamela K Cassiday; Gary Cage; Mark S Peppler; Deborah Shea; David Boxrud; Gary N Sanden
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Maternal immunity provides protection against pertussis in newborn piglets.

Authors:  Shokrollah Elahi; Rachelle M Buchanan; Lorne A Babiuk; Volker Gerdts
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994.

Authors:  Mark S Peppler; Sharee Kuny; Anna Nevesinjac; Christina Rogers; Yvon R de Moissac; Kathleen Knowles; Manon Lorange; Gaston De Serres; James Talbot
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s.

Authors:  Leo M Schouls; Han G J van der Heide; Luc Vauterin; Paul Vauterin; Frits R Mooi
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

Review 5.  Strategies and new developments to control pertussis, an actual health problem.

Authors:  María Emilia Gaillard; Daniela Bottero; Griselda Moreno; Martin Rumbo; Daniela Hozbor
Journal:  Pathog Dis       Date:  2015-08-09       Impact factor: 3.166

6.  Antigenic divergence of Bordetella pertussis isolates in Taiwan.

Authors:  Shu-Man Yao; Yu-Chi Lin; Chen-Ying Chou; Ying-Yan Chen; Miao-Ju Hsiao; Hour-Young Chen; Jer-Jea Yan; Hsun-Pi Su; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

7.  Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.

Authors:  Daniel N Wolfe; Girish S Kirimanjeswara; Eric T Harvill
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

8.  A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil.

Authors:  P M Luz; C T Codeço; G L Werneck; C J Struchiner
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

Review 9.  Bordetella pertussis: the intersection of genomics and pathobiology.

Authors:  Andrew Preston
Journal:  CMAJ       Date:  2005-07-05       Impact factor: 8.262

10.  Pathogen adaptation under imperfect vaccination: implications for pertussis.

Authors:  Michiel van Boven; Frits R Mooi; Joop F P Schellekens; Hester E de Melker; Mirjam Kretzschmar
Journal:  Proc Biol Sci       Date:  2005-08-07       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.